Xeureka

Xeureka Inc., established by Mitsui & Co., Ltd., is a cutting-edge company that specializes in early drug discovery research using state-of-the-art computer technology, including AI and simulations. The company was founded to address several industrial issues in the pharmaceutical industry, such as high R&D costs, low success rates, and long development lead times for new drug discovery. By extensively using computer technology in all aspects of drug development, Xeureka aims to dramatically improve efficiency and increase success rates.

This approach contributes to the timely provision of high-quality, economically priced drugs to people affected by diseases, especially cancer. Xeureka builds its business in collaboration with Mitsui Knowledge Industry, a Mitsui subsidiary that has been working in the field of bioinformatics for half a century. The company is committed to evolving high-added-value business models and contributing to sustainable social development.